Unaudited Financial Results for the Quarter ended 31st December, 2007
(Rs. In Lacs)
Sr.
No.
Particulars
Quarter ended
31.12.2007
(Unaudited)
Quarter ended
31.12.2006
(Unaudited)
9 Months
ended
31.12.2007 (Unaudited)
9 Months
ended
31.12.2006 (Unaudited)
Year ended 31.03.2007 (Audited)
1
Net Sales / Income from Operations
2892.97
3010.22
9178.26
9494.35
12840.07
2
Other income
3.04
0.29
6.45
2.86
22.96
3
Total (1+2)
2896.01
3010.51
9184.71
9497.21
12863.03
4
Expenditure
a) (Increase) / Decrease in Stock-in-Trade & Work in Progress
(110.63)
(394.83)
141.50
(513.12)
(85.28)
b) Consumption of Raw Materials
2265.63
2225.35
6141.42
6447.47
8364.74
c) Employee Cost
407.44
334.37
1197.86
1017.83
1519.87
d) Depreciation and Amortisation
1187.49
1229.46
3646.45
3688.38
4905.80
e) Other Expenditure
836.46
366.22
2334.81
1285.10
2449.85
Total
4586.39
3760.57
13462.04
11925.66
17154.98
5
Interest
834.51
41.87
922.59
85.78
528.31
6
Exceptional Items
-
-
-
-
-
7
Profit / (Loss) from Ordinary Activities before Tax (3) -
(4+5+6)
(2524.89)
(791.93)
(5199.92)
(2514.23)
(4820.26)
8
Tax Expense
- Fringe Benefit Tax
8.75
2.10
16.47
4.12
22.55
- Deffered Tax Assets
-
-
-
-
2444.49
9
Profit / (Loss) from Ordinary Activities after Tax (7-8)
(2533.64)
(794.03)
(5216.39)
(2518.35)
(7287.30)
10
Extraordinary Items
415.78
-
415.78
-
(8474.80)
11
Net Profit /(Loss) (9-10)
(2117.86)
(794.03)
(4800.61)
(2518.35)
(15762.10)
12
Paid-up Equity Share Capital of Face Value of Rs.2/- each
7141.75
4220.80
7141.75
4220.80
4220.80
13
Reserves excluding revaluation reserves
43907.72
14 (a)
Earning Per Share
before Extraordinary Items (in Rs.) -
Basic & Diluted
(1.13)
(0.38)
(2.37)
(1.19)
(3.45)
(b)
Earning Per Share after Extraordinary Items (in Rs.) -
Basic & Diluted
(0.94)
(0.38)
(2.19)
(1.19)
(7.47)
15
Public Shareholding
Number of Shares
202715952
140708412
202715952
140708412
140708412
Percentage of shareholding
56.77%
66.67%
56.77%
66.67%
66.67%
Notes:
The above results were reviewed by the audit committee and have been taken on record by the Board of Directors in its meeting held on 15th January, 2008. A limited review of the same has been carried out by the statutory auditors.
(i) A sum of Rs. 7976.40 Lacs has been received from GL India Mauritius III Ltd. towards subscription of 3,85,30,000 Equity Shares of Rs.2/- at a premium of Rs.18/- per Share and also towards 10% money payable on subscription of 1,35,20,000 Convertible Naked Warrants, allotted on Preferential basis.
(ii)The company has received a sum of Rs. 6600.00 Lacs from promoters during the quarter towards balance amount payable on subscription of 1000 Naked Warrants converted into 10,00,00,000 Equity Shares of Rs.2/- each at a premium of Rs.8/- per Share .
(iii)The proceeds of Rs. 14576.40 Lacs received on account of abovenoted preferential alottment has been utilised as under-Payment to Banks/FI's towards settlement of their dues - Rs. 14285.59 LacsWorking Capital - Rs. 290.81 Lacs
Other expenditure includes a sum of Rs. 280.21 Lacs paid towards debt restructuring expenses.
Interest includes a sum of Rs. 784.63 Lacs towards payment of interest to banks/financial institutions paid under One Time Settlement (OTS) .
Pending settlement with Fixed Depositors and three lenders, interest of Rs. 942.82 Lacs has not been provided. Scheme of arrangement & compromise under Section 391 of Companies Act, 1956 is pending adjudication before Hon'ble Himachal Pradesh High Court at Shimla.
Extraordinary items represents Waiver received from banks/Financial Institutions which has been settled by way of One Time Settlement (OTS) during the quarter.
During the Quarter, 4 shareholders' complaint were received which were attended/redressed.
The Company is exclusively engaged in the Pharmaceutical Business segment. Capital employed as on 31st December, 2007 is Rs. 72632.61 Lacs.
Consolidated Sales & Profit(Loss) after tax for quarter ended December 31, 2007 stands at Rs. 3445.04 Lacs & (Rs. 2254.14) Lacs respectively whereas EPS for the quarter stands at (Rs. 1.03).
The comparative figures are regrouped and reclassified, wherever considered necessary.
